EUVIMEDEUVIMED entdecken
CrossrefInfokarte

COQ7-Related Juvenile-Onset Motor Neuronopathy: A New Pathogenetic Dysfunction Associated with Motor Neuron Disease

Paulo Victor Sgobbi de Souza, Igor Braga Farias, Paulo de Lima Serrano, Bruno de Mattos Lombardi Badia, Ana Carolina dos Santos Jorge, Glenda Barbosa Barros, Hélvia Bertoldo de Oliveira, Samia Rogatis Calil, Isabela Danziato Fernandes, Roberta Correa Ribeiro, Vinícius Lopes Braga, Roberta Ismael Lacerda Machado, Marco Antônio Troccoli Chieia, Wladimir Bocca Vieira de Rezende Pinto, Acary Souza Bulle Oliveira

Sclerosis · 2023

DOI: 10.3390/sclerosis1010004 ↗
AbstractBibliografische Angaben

Abstract

A 38-year-old Brazilian man presented with slowly progressive quadriparesis since age 11 years. He progressed over 15 years with symptoms restricted to the lower limbs, and since then, with a progressive compromise of the upper limbs. His deceased brother had a similar clinical presentation. Examination showed spastic dysarthria, global amyotrophy, brisk tendon reflexes in the lower limbs, symmetrical quadriparesis, and fasciculations in the four limbs. Neurophysiological studies disclosed acute and chronic signs of denervation and chronic reinnervation involving the cervical, thoracic, and lumbosacral myotomes, with normal sensory conduction study. Fibrillation potentials, fasciculations, and positive sharp waves involved mainly the upper limbs. A diagnosis of long-standing juvenile-onset motor neuronopathy was established. Genetic testing identified the possibly pathogenic variant c.3G>T (p.Met1?) in homozygosity in the COQ7 gene. This report highlights the importance of considering a potentially treatable metabolic dysfunction as the primary mechanism in cases of juvenile motor neuron disease.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →